STAT Plus: These 10 scientists are leading a new generation of gene editors developing CRISPR medicines
CRISPR
CRISPR is a gene editing technology that allows scientists to make precise changes to DNA. Here you can learn about the companies developing CRISPR-based treatments, and the tremendous potential in its use.
For the latest CRISPR advances, check out STAT’s searchable CRISPR Trackr.
Latest
STAT Plus: Feud between Prime and Tessera, two gene-editing companies, spills out into public
STAT Plus: Editas tacks again, steering from lead sickle cell treatment to new one
STAT Plus: SalioGen Therapeutics hit by layoffs, as gene-editing biotechs continue to struggle
Crypto for CRISPR, a new RNAi startup, & a Nobel for AI
STAT Plus: As U.S. efforts stall, China pushes ahead with CRISPR treatments for muscular dystrophy
STAT Plus: A pariah in science, the ‘CRISPR babies’ researcher gains support from a U.S. cryptocurrency entrepreneur
STAT Plus: Prime Medicine shrinks CRISPR ambitions and gets cash infusion from Bristol Myers Squibb
All Coverage
advertisement
